foxo4-dri senolytic human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound Package:Single Pack TB-500 Blend The Peptide Therapy Protocols
SKU: 83908919572
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20





















